Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Fetal Hemoglobin Research and Clinical Relevance in Sickle Cell Disease.
Physiology (Bethesda, Md.)·2025
Nonclinical evaluation of renizgamglogene autogedtemcel for SCD and TDT.
Molecular therapy : the journal of the American Society of Gene Therapy·2025
Hematopoietic stem cell therapy with gene modification to treat sickle cell disease.
Stem cells translational medicine·2025
Gene therapy: Have the risks associated with viral vectors been solved?
Current opinion in molecular therapeutics·2011
Teduglutide, a glucagon-like peptide-2 analog for the treatment of gastrointestinal diseases, including short bowel syndrome.
Current opinion in molecular therapeutics·2010
Dulaglutide, a long-acting GLP-1 analog fused with an Fc antibody fragment for the potential treatment of type 2 diabetes.
Current opinion in molecular therapeutics·2010
Corticorelin, a synthetic human corticotropin-releasing factor analog, for the treatment of peritumoral brain edema.
Current opinion in molecular therapeutics·2010
Mogamulizumab, a humanized mAb against C-C chemokine receptor 4 for the potential treatment of T-cell lymphomas and asthma.
Current opinion in molecular therapeutics·2010
Gevokizumab, an anti-IL-1β mAb for the potential treatment of type 1 and 2 diabetes, rheumatoid arthritis and cardiovascular disease.
Current opinion in molecular therapeutics·2010